Voloridge Investment Management’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.1M | Sell |
114,275
-101,898
| -47% | -$22.8M | 0.1% | 279 |
|
|
2025
Q4 | $46.1M | Sell |
216,173
-18,224
| -8% | -$3.76M | 0.16% | 160 |
|
|
2025
Q3 | $46.6M | Sell |
234,397
-28,870
| -11% | -$5.38M | 0.16% | 156 |
|
|
2025
Q2 | $45.4M | Sell |
263,267
-82,751
| -24% | -$13.5M | 0.17% | 153 |
|
|
2025
Q1 | $53.9M | Buy |
346,018
+47,022
| +16% | +$6.72M | 0.2% | 142 |
|
|
2024
Q4 | $41.2M | Sell |
298,996
-98,017
| -25% | -$12.9M | 0.15% | 196 |
|
|
2024
Q3 | $59.3M | Buy |
397,013
+50,795
| +15% | +$6.86M | 0.22% | 122 |
|
|
2024
Q2 | $47.2M | Buy |
346,218
+38,719
| +13% | +$5.27M | 0.18% | 176 |
|
|
2024
Q1 | $46.5M | Buy |
307,499
+234,164
| +319% | +$33.4M | 0.17% | 173 |
|
|
2023
Q4 | $9.24M | Buy |
73,335
+53,427
| +268% | +$5.33M | 0.04% | 490 |
|
|
2023
Q3 | $1.86M | Buy |
+19,908
| New | +$1.86M | 0.01% | 940 |
|
|
2022
Q2 | – | Sell |
-1,887
| Closed | -$221K | – | 1418 |
|
|
2022
Q1 | $221K | Sell |
1,887
-2,772
| -59% | -$321K | ﹤0.01% | 1290 |
|
|
2021
Q4 | $627K | Sell |
4,659
-1,695
| -27% | -$252K | ﹤0.01% | 1372 |
|
|
2021
Q3 | $1.01M | Buy |
+6,354
| New | +$870K | 0.01% | 1281 |
|
|
2021
Q1 | – | Sell |
-5,618
| Closed | -$937K | – | 1376 |
|
|
2020
Q4 | $937K | Sell |
5,618
-1,439
| -20% | -$238K | 0.01% | 985 |
|
|
2020
Q3 | $1.09M | Buy |
7,057
+116
| +2% | +$16.7K | 0.01% | 915 |
|
|
2020
Q2 | $1.03M | Buy |
+6,941
| New | +$953K | 0.01% | 844 |
|
|
2020
Q1 | – | Sell |
-33,800
| Closed | -$4.7M | – | 1083 |
|
|
2019
Q4 | $4.7M | Buy |
33,800
+9,439
| +39% | +$1.05M | 0.09% | 284 |
|
|
2019
Q3 | $2.35M | Buy |
24,361
+22,291
| +1,077% | +$2.49M | 0.04% | 408 |
|
|
2019
Q2 | $238K | Sell |
2,070
-4,796
| -70% | -$574K | 0.01% | 679 |
|
|
2019
Q1 | $808K | Buy |
+6,866
| New | +$601K | 0.02% | 548 |
|
Other funds holding ASND
RCM
ACA
